CSTL Kronos AI forecast
A 30-trading-day price forecast for Castle Biosciences Inc. (CSTL) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Castle Biosciences Inc. at $29.63 on 2026-12-08, −14.1% from the last close of $34.51 on 2026-10-27. Eight out of ten sampled paths end between $26.42 and $32.32, and 0 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of CSTL
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $34.31 | $32.69 | $37.23 |
| 2026-11-10 | $34.75 | $33.34 | $37.69 |
| 2026-11-17 | $34.85 | $32.55 | $36.89 |
| 2026-11-24 | $32.36 | $30.63 | $34.30 |
| 2026-12-01 | $30.08 | $27.78 | $32.86 |
| 2026-12-08 | $29.63 | $26.42 | $32.32 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for CSTL?
- Kronos AI's median forecast for CSTL is $29.63 in 30 trading days, −14.1% from the last close, with a 10–90% range of $26.42 to $32.32.
- Is the CSTL Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- UNH — UnitedHealth Group Incorporated
- ELV — Elevance Health Inc.
- CI — The Cigna Group
- NTRA — Natera Inc.
- HUM — Humana Inc.
- ILMN — Illumina Inc.